Arnold Porter

AUGUST 20, 2021

The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) recently released the Acceptance Review Guideline on Biological Products Changes (for Trial Implementation). Latest Developments in China’s Drug Change Management Regulations. ???????????????. “????”???????????????????????????????????????2019?????????????20???????????????????????????????????????????????????????????.

Regulations 64

Regulations 2019 Law 2020 64

Arnold Porter

SEPTEMBER 27, 2021

On September 10, 2021, the Acting Commissioner of the Food and Drug Administration (FDA), Janet Woodcock, published a letter to the US Patent and Trademark Office (USPTO) seeking increased exchange and collaboration between the two agencies relating to grants of patent rights to pharmaceutical innovations.

Law 97

Law 2021 Regulations Technology 97

Arnold Porter

JANUARY 9, 2023

N: See Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower Cost Drug Products (Jun. 16, 2022), available here and FTC Press Release, FTC Launches Inquiry Into Prescription Drug Middlemen Industry (Jun. A trial on the issue is currently set to begin April 2023. Read the Complaint.

2022 52

2022 Law Government Technology 52